SEC Comment Letter for Streamex Corp. (STEX) (CIK 0001530766) (STEX) — Aug 18, 2017
Streamex Corp. (STEX) (CIK 0001530766)
Date: Aug. 18, 2017 · CIK: 0001530766 · Accession: 0000000000-17-029304
AI Filing Summary & Sentiment
Reasoning
Letter
Mail Stop 3030 August 17, 2017 Via E -mail Kenneth Londoner Chief Executive Officer BioSig Technologies, Inc. 8441 Wayzata Blvd., Suite 240 Minneapolis, Minnesota 55426
Re: BioSig Technologies, Inc. Amendment No. 1 to Registration Statement on Form S -1 Filed August 3, 2017 File No. 333 -218583
Dear Mr. Londoner :
We have limited our review of your amended registration statement and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure.
Please respond to this letter by amending your registration statement and providing the requested information . If you do not believe our comments apply t o your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response.
After reviewing any amendment to your registration statement and the information you provide in response to these comments, we may have additional comments. Unless we note otherwise, our references to prior comments are to comments in our June 29, 2017 letter .
Selling Shareholders, page 49
1. Expand your response to prior comment 1 to provide your legal analysis for the exemption upon whi ch you relied to iss ue the warrants to Laidlaw & Co. employees . In this regard, it is unclear why Laidlaw & Co.’s status as an accredited investor would exempt the issuance of securities to its employees. Also, clarify your added disclosure that you issu ed the securities to the employees of Laidlaw & Co. “as designees.”
Kenneth Londoner BioSig Technologies, Inc. August 17, 2017 Page 2
Please contact Heather Percival at (202) 551 -3498 or me at (202) 551 -3528 with any questions.
Sincerely,
/s/ Amanda Ravitz
Show Raw Text
Mail Stop 3030 August 17, 2017 Via E -mail Kenneth Londoner Chief Executive Officer BioSig Technologies, Inc. 8441 Wayzata Blvd., Suite 240 Minneapolis, Minnesota 55426 Re: BioSig Technologies, Inc. Amendment No. 1 to Registration Statement on Form S -1 Filed August 3, 2017 File No. 333 -218583 Dear Mr. Londoner : We have limited our review of your amended registration statement and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure. Please respond to this letter by amending your registration statement and providing the requested information . If you do not believe our comments apply t o your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to these comments, we may have additional comments. Unless we note otherwise, our references to prior comments are to comments in our June 29, 2017 letter . Selling Shareholders, page 49 1. Expand your response to prior comment 1 to provide your legal analysis for the exemption upon whi ch you relied to iss ue the warrants to Laidlaw & Co. employees . In this regard, it is unclear why Laidlaw & Co.’s status as an accredited investor would exempt the issuance of securities to its employees. Also, clarify your added disclosure that you issu ed the securities to the employees of Laidlaw & Co. “as designees.” Kenneth Londoner BioSig Technologies, Inc. August 17, 2017 Page 2 Please contact Heather Percival at (202) 551 -3498 or me at (202) 551 -3528 with any questions. Sincerely, /s/ Amanda Ravitz Amanda Ravitz Assistant Director Office of Electronics and Machinery cc: Rick A. Werner, Esq. Haynes and Boone, LLP